CVAC
Income statement / Annual
Last year (2023), CureVac N.V.'s total revenue was $53.76 M,
a decrease of 20.26% from the previous year.
In 2023, CureVac N.V.'s net income was -$260.17 M.
See CureVac N.V.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$53.76 M
|
$67.42 M
|
$102.99 M
|
$48.90 M
|
$17.42 M
|
$12.87 M
|
| Cost of Revenue |
$124.37 M |
$183.99 M |
$238.20 M |
$14.17 M |
$27.98 M |
$17.74 M |
| Gross Profit |
-$70.61 M |
-$116.57 M |
-$135.21 M |
$34.73 M |
-$10.57 M |
-$4.87 M |
| Gross Profit Ratio |
-1.31 |
-1.73 |
-1.31 |
0.71 |
-0.61 |
-0.38 |
| Research and Development
Expenses |
$115.72 M
|
$62.55 M
|
$815.91 M
|
$113.81 M
|
$43.24 M
|
$41.72 M
|
| General & Administrative
Expenses |
$76.01 M
|
$88.99 M
|
$87.20 M
|
$45.03 M
|
$42.18 M
|
$20.42 M
|
| Selling & Marketing
Expenses |
$424,000.00
|
$417,000.00
|
$1.74 M
|
$733,000.00
|
$1.76 M
|
$1.09 M
|
| Selling, General &
Administrative Expenses |
$76.43 M
|
$89.41 M
|
$88.94 M
|
$45.76 M
|
$43.94 M
|
$21.50 M
|
| Other Expenses |
$11.44 M |
-$17.68 M |
-$627.79 M |
-$870,000.00 |
$1.75 M |
$4.73 M |
| Operating Expenses |
$211.75 M |
$134.28 M |
$277.06 M |
$158.70 M |
$88.93 M |
$67.95 M |
| Cost And Expenses |
$327.97 M |
$318.27 M |
$515.25 M |
$158.70 M |
$116.91 M |
$85.70 M |
| Interest Income |
$16.73 M |
$4.01 M |
$10.10 M |
$2.07 M |
$833,000.00 |
$1.97 M |
| Interest Expense |
$2.49 M |
$3.71 M |
$10.34 M |
$22.10 M |
$1.46 M |
$275,000.00 |
| Depreciation &
Amortization |
$23.39 M
|
$26.16 M
|
$35.88 M
|
$13.61 M
|
$4.76 M
|
$3.89 M
|
| EBITDA |
-$234.09 M
|
-$209.39 M
|
-$386.49 M
|
-$123.10 M
|
-$91.50 M
|
-$69.85 M
|
| EBITDA Ratio |
-4.35 |
-3.31 |
-3.75 |
-2.25 |
-5.25 |
-5.21 |
| Operating Income Ratio
|
-5.1
|
-3.7
|
-4
|
-2.54
|
-5.71
|
-5.66
|
| Total Other
Income/Expenses Net |
$14.24 M
|
$302,000.00
|
-$235,000.00
|
-$20.03 M
|
-$627,000.00
|
$1.69 M
|
| Income Before Tax |
-$259.97 M |
-$249.16 M |
-$412.50 M |
-$129.80 M |
-$100.13 M |
-$71.13 M |
| Income Before Tax Ratio
|
-4.84
|
-3.7
|
-4.01
|
-2.65
|
-5.75
|
-5.53
|
| Income Tax Expense |
$198,000.00 |
-$126,000.00 |
-$782,000.00 |
-$726,000.00 |
-$252,000.00 |
$110,000.00 |
| Net Income |
-$260.17 M |
-$249.03 M |
-$411.72 M |
-$129.07 M |
-$99.87 M |
-$71.24 M |
| Net Income Ratio |
-4.84 |
-3.69 |
-4 |
-2.64 |
-5.73 |
-5.54 |
| EPS |
-1.18 |
-1.32 |
-2.21 |
-0.98 |
-0.53 |
-0.4 |
| EPS Diluted |
-1.18 |
-1.32 |
-2.21 |
-0.98 |
-0.53 |
-0.4 |
| Weighted Average Shares
Out |
$220.48 M
|
$189.07 M
|
$186.01 M
|
$132.20 M
|
$186.91 M
|
$175.97 M
|
| Weighted Average Shares
Out Diluted |
$220.83 M
|
$189.07 M
|
$186.01 M
|
$132.20 M
|
$186.91 M
|
$175.97 M
|
| Link |
|
|
|
|
|
|
